共 106 条
[1]
Enzinger PC(2003)Esophageal cancer N Engl J Med. 349 2241-2252
[2]
Mayer RJ(2012)Preoperative chemoradiotherapy for esophageal or junctional cancer N Engl J Med. 366 2074-2084
[3]
van Hagen P(2010)Pathologic response after neoadjuvant therapy is the major determinant of survival in patients with esophageal cancer Ann Surg Oncol. 17 1159-1167
[4]
Hulshof MC(2012)Pathologic nonresponders after neoadjuvant chemoradiation for esophageal cancer demonstrate no survival benefit compared with patients treated with primary esophagectomy Ann Surg Oncol. 19 1678-1684
[5]
van Lanschot JJ(2014)Lymph node retrieval during esophagectomy with and without neoadjuvant chemoradiotherapy: Prognostic and therapeutic impact on survival Ann Surg. 260 786-92
[6]
Meredith KL(2010)Influence of neoadjuvant chemoradiation on the number and size of analyzed lymph nodes in esophageal cancer Ann Surg Oncol. 17 3187-3194
[7]
Weber JM(2015)Impact of neoadjuvant chemoradiation on lymph node status in esophageal cancer: Post hoc analysis of a randomized controlled trial Ann Surg. 261 902-908
[8]
Turaga KK(2008)The number of metastatic lymph nodes and the ratio between metastatic and examined lymph nodes are independent prognostic factors in esophageal cancer regardless of neoadjuvant chemoradiation or lymphadenectomy extent Ann Surg. 247 365-371
[9]
Dittrick GW(2008)Effect of the number of lymph nodes sampled on postoperative survival of lymph node-negative esophageal cancer Cancer. 112 1239-1246
[10]
Weber JM(2012)Pathologic lymph node ratio is a predictor of survival in esophageal cancer Ann Thorac Surg. 94 1643-1651